http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105732736-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04 |
| filingDate | 2016-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105732736-B |
| titleOfInvention | A kind of preparation method of phenylpropanoids |
| abstract | The present invention relates to pharmaceutical technology fields, disclose a kind of preparation method of phenylpropanoids, more particularly to isolated a kind of phenylpropanoids from the dry root of Flemingia macrophylla, the phenylpropanoids isolate and purify obtained through solvent extraction, column chromatography for separation, preparation liquid phase, the phenylpropanoids obtained through the method for the present invention are to report for the first time, purity is high.It is demonstrated experimentally that obtained new phenylpropanoids can inhibit the content of cellular inflammation factor NO and the expressional function of cellular inflammation factor TNF-α, have to hydroxyl radical free radical（-OH）Inhibiting effect, and then have anti-inflammatory and antioxidant activity, be beneficial to the treatment of the various diseases associated with inflammation such as cervicitis, endometritis, pelvic inflammatory disease, mazoitis, sphagitis and/or arthritis, can by the compound develop at new drug.Heretofore described structural formula of compound is formula（Ⅰ）Shown in phenylpropanoids and its pharmaceutically acceptable salt. （Ⅰ）. |
| priorityDate | 2016-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.